10 employees
Equalix develops and commercializes products in regenerative medicine for dermatological, neurological, and cardiovascular applications.
2020
$50K
from 1 investors over 1 rounds
Eqalix raised $50K on March 26, 2013
Investors: The Nanotechnology Institute